News

Sentien Biotechnologies CEO Brian Miller was featured on the front page of BioWorld™ Today on September 15, 2016.  Mr. Miller participated on a Biopharm America panel discussing “How to Value Your Startup” in Boston, MA.  Joining him on the panel were Martin Heidecker, director and investment manager with the Boehringer Ingelheim Venture Fund, Patrik Frei, Founder of CEO of Venture Valuation, and Ryan Muldoon, CEO of PrEP Biopharma.  Read more here:  http://www.bioworld.com/content/its-best-take-broad-view-early-focus-mutual-wins (subscription may be required).